Aligos Therapeutics, Inc. (ALGS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Aligos Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.81x | -1.90x | -4.71x | -10.59x | -92.16x | -217.66x |
| P/B Ratio | 1.72x | -8.61x | 4.48x | 9.79x | 64.02x | 107.37x |
| P/S Ratio | 42.14x | 63.27x | 26.59x | 73.13x | 2713.26x | 0.00x |
| Profitability | ||||||
| Gross Margin | 57.5% | 100.0% | 100.0% | 100.0% | 100.0% | 0.0% |
| Operating Margin | -4024.9% | -2259.9% | -567.5% | -701.7% | -2943.8% | 0.0% |
| Net Margin | -1106.7% | -3326.0% | -564.6% | -690.6% | -2944.1% | 0.0% |
| EBITDA Margin | -3982.4% | -2193.5% | -547.7% | -675.2% | -2857.1% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.90x | 2.86x | 5.90x | 4.03x | 5.25x | 8.26x |
| Quick Ratio | 3.90x | 2.86x | 5.90x | 4.03x | 5.25x | 8.26x |
| Leverage | ||||||
| Debt/Equity | 0.10x | -0.29x | 0.12x | 0.12x | 0.08x | 0.06x |
YoY = year-over-year change. Source: FMP..